It seems that CFS-PGRN levels can be used to predict the type of FTD as it mirrors the FTD-subtype—the level is significantly lower in cases with TDP-43 pathology lacking a GRN mutation [130]. The gene discussed is TARDBP; the disease is frontotemporal dementia.